Utrecht, Netherlands · Founded 2013 · Privately Held (backing)
Developer of medical devices designed to be used for the treatment of diabetes. Kaleido is based in Utrecht, Netherlands and was founded in 2013. It has raised $194 million.
Last price · $/share
—
Implied valuation
—
Total raised
$193.6M
Last round
—
Team — not yet on record
No current team members for Kaleido are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kaleido with a free account
·Watch Kaleido: the Monday email on marks, rounds and moves
